NEOS Investment Management’s AbbVie ABBV Stock Holding History

NEOS Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.1M	Buy	286,410 +26,944	+10%	+$5.8M	0.27%	60
2026 Q1	$56.4M	Sell	259,466 -2,319	-0.9%	-$514K	0.29%	63
2025 Q4	$59.8M	Buy	261,785 +35,289	+16%	+$8.04M	0.35%	57
2025 Q3	$52.4M	Buy	226,496 +62,812	+38%	+$12.8M	0.39%	47
2025 Q2	$30.4M	Buy	163,684 +31,763	+24%	+$5.9M	0.38%	50
2025 Q1	$27.6M	Buy	131,921 +36,132	+38%	+$7.02M	0.52%	38
2024 Q4	$17M	Buy	95,789 +22,381	+30%	+$4.11M	0.4%	46
2024 Q3	$14.5M	Buy	73,408 +8,123	+12%	+$1.52M	0.44%	45
2024 Q2	$11.2M	Buy	65,285 +20,916	+47%	+$3.46M	0.46%	40
2024 Q1	$8.08M	Buy	44,369 +19,313	+77%	+$3.33M	0.5%	38
2023 Q4	$3.88M	Buy	25,056 +7,172	+40%	+$1.05M	0.37%	52
2023 Q3	$2.67M	Buy	+17,884	New	+$2.63M	0.34%	60

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NEOS Investment Management's ABBV Position: Q2 2026 in Review

NEOS Investment Management increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $5.8M and bringing the position to 286,410 shares worth $72.1M. The position accounts for 0.27% of the portfolio, ranked #60.

NEOS Investment Management first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

NEOS Investment Management held 286,410 shares of AbbVie worth $72.1M as of Q2 2026.
NEOS Investment Management bought 26,944 AbbVie shares in Q2 2026, an estimated $5.8M.
AbbVie made up 0.27% of NEOS Investment Management's portfolio in Q2 2026, its #60 holding.
NEOS Investment Management first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.